The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
about
The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for StrokeElevated trimethylamine-N-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function.Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery.Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies.Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies.Gut Microbiota and Atherosclerosis.Gut microbiota and acute coronary syndromes: ready for use in the emergency room?Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: A randomized controlled trial.Microbial modulation of cardiovascular disease.Associations of current diet with plasma and urine TMAO in the KarMeN study: direct and indirect contributions.A Non-Targeted LC-MS Profiling Reveals Elevated Levels of Carnitine Precursors and Trimethylated Compounds in the Cord Plasma of Pre-Eclamptic Infants
P2860
Q28069455-197A527B-CCFC-479A-94A9-5BC3AB4DC938Q33731986-E6D00927-EC15-46C6-B7C7-AAD1FB5B7D28Q36340545-176A79EB-90DB-4787-B181-38D51F135A1EQ37076037-E4F215C5-1213-4858-B57A-81BE464E738AQ38637363-0A6C5F7A-2FC2-4711-80EC-57C33245291DQ38701617-1F1B7FBC-0625-4FD0-A1B8-654DA3168B4BQ40079055-D603B15F-CBB3-4D96-9C56-8DCC990C5C98Q40345971-631F824C-8F22-41AE-8B26-D85AFCB8EABEQ46523205-AF79764D-7694-492F-868A-9F87BE5DCA16Q50144047-501EDC4B-D086-440C-8111-04C693355363Q50201612-3BFEAF49-AB8F-4514-8472-57A3FBF5AFF5Q57050288-FF59F903-F648-4380-AD2D-A5739D98B658
P2860
The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
The Carnitine-butyrobetaine-tr ...... with carotid atherosclerosis.
@en
type
label
The Carnitine-butyrobetaine-tr ...... with carotid atherosclerosis.
@en
prefLabel
The Carnitine-butyrobetaine-tr ...... with carotid atherosclerosis.
@en
P2093
P50
P1433
P1476
The Carnitine-butyrobetaine-tr ...... with carotid atherosclerosis.
@en
P2093
Asbjørn Svardal
Azhar Abbas
David Russell
Frode Reier-Nilsen
Ida Gregersen
Johannes E R Hov
Karolina Skagen
Marius Trøseid
Rolf K Berge
Sverre Holm
P356
10.1016/J.ATHEROSCLEROSIS.2016.01.033
P577
2016-02-05T00:00:00Z